Related Experiment Video
Updated: May 21, 2026
08:13
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Daily dosing prophylaxis for haemophilia: a randomized crossover pilot study evaluating feasibility and efficacy
K Lindvall1, J Astermark, S Björkman
1Malmö Centre for Thrombosis and Haemostasis, Lund University, Malmö, Sweden. karin.lindvall@med.lu.se
Summary
Daily prophylaxis for haemophilia may reduce costs by 30% but increased bleeding events and decreased quality of life for some patients. Further research is needed before clinical routine adoption.
Area of Science:
- Hematology
- Pharmacoeconomics
Background:
- Regular replacement therapy (prophylaxis) for hemophilia improves quality of life and prevents joint damage compared to on-demand treatment.
- Prophylaxis is associated with significantly higher treatment costs.
- Pharmacokinetic principles suggest dose interval reduction may lower costs.
Purpose of the Study:
- To evaluate the feasibility, cost-effectiveness, and efficacy of daily factor concentrate dosing for hemophilia prophylaxis.
- To compare daily prophylaxis with standard prophylactic regimens in terms of concentrate consumption and bleeding events.
Main Methods:
- A prospective, randomized, 12+12 month crossover pilot study.
- 13 hemophilia patients were randomized to either standard prophylaxis or daily prophylaxis.
- Daily dosing was adjusted to maintain trough levels equivalent to standard prophylaxis.
Main Results:
- Daily prophylaxis achieved a 30% reduction in factor concentrate costs.
- Some patients experienced an increase in bleeding events with daily prophylaxis.
- Patients reported decreased quality of life and increased stress during daily prophylaxis.
Conclusions:
- Daily prophylaxis may be feasible and effective for select hemophilia patients, offering significant cost savings.
- Increased bleeding and reduced quality of life are potential drawbacks of daily prophylaxis.
- Larger studies are required to validate daily prophylaxis for routine clinical use.
Related Concept Videos
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:16Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...